- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 21, 2025 | 77.94M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $61.24M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $70.8M |
| Current Assets | FY 2024 · Dec 31, 2023 | $285.62M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.11B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 71.55M sh |
| Capex | FY 2024 · Dec 31, 2022 | $8.55M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $7.54M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $154.25M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.51 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.51 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $73.2M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $40.6M |
| Net Income | FY 2024 · Dec 31, 2022 | −$36.56M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$41.08M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $175.68M |
| Revenue | FY 2024 · Dec 31, 2022 | $296.54M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $1.1B |